⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

November 2, 2016Journal of Gynecologic OncologyOpen Access

The detection of sentinel lymph nodes in laparoscopic surgery for uterine cervical cancer using 99m-technetium-tin colloid, indocyanine green, and blue dye

Tomohito Tanaka Yoshito Terai K Ashihara Satoshi Tsunetoh Hiroyuki Akagi Takashi Yamada Masahide Ohmichi

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Among the examined tracers, (99m)Tc had the highest detection of SLN mapping in patients with uterine cervical cancer. Patients with local advanced cervical cancer with/without NAC treatment might be unsuited for SLN mapping. SLN mapping is feasible and results in an excellent detection rate in patients with <2-cm-diameter cervical cancer. Laparoscopic surgery is the best procedure for SLN detection in patients with early-stage disease.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Tanaka et al. (2016) studied this question.

synapsesocial.com/papers/69d81c79a2a48916bbbef17d https://doi.org/10.3802/jgo.2017.28.e13

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Current status of fertility preservation for borderline ovarian tumor in Asian regions: results from ASGO-special task force for fertility preservation; part I. Fertility-sparing treatment for borderline ovarian tumorJournal of Gynecologic Oncology · 2026
2Effectiveness of first-line niraparib maintenance in Korean patients with advanced ovarian cancer: a multicenter retrospective cohort studyJournal of Gynecologic Oncology · 2026
3Current status of fertility preservation for borderline ovarian tumor in Asian countries: results from ASGO-special task force for fertility preservation; part II. Fertility and pregnancy planning following initial treatmentJournal of Gynecologic Oncology · 2026
4Correlation of bevacizumab relative dose intensity with first-line treatment outcomes in advanced epithelial ovarian cancerJournal of Gynecologic Oncology · 2026
5Changes and clinical impact of HER3 and ERBB3 expression in primary and recurrent ovarian cancerJournal of Gynecologic Oncology · 2026

Prognosis and risk factors by histologic type of malignant ovarian germ cell tumors in Japan: a JSOG gynecologic tumor registry-based studyJournal of Gynecologic Oncology · 2026
Post-marketing safety assessment of mirvetuximab soravtansine: a disproportionality analysis based on the FDA Adverse Event Reporting SystemJournal of Gynecologic Oncology · 2026
Survey on the current status of novel cancer drug therapies for gynecological cancers in Japan: a nationwide survey by the Japan Society of Obstetrics and Gynecology (JSOG)Journal of Gynecologic Oncology · 2026
Long-term trends and future projections of cervical cancer burden in China, 1990–2023: a Global Burden of Disease 2023 analysisJournal of Gynecologic Oncology · 2026
Clinicopathologic features and outcomes of patients with microsatellite instability-high endometrial cancer treated with pembrolizumab in Japan: the KCOG-G1902S/1903S studyJournal of Gynecologic Oncology · 2026

More from Journal of Gynecologic Oncology

More from Osaka Medical and Pharmaceutical University